A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis
Clinical trial NCT04697056 · TERMINATED
Trial details
- NCT number
- NCT04697056
- Sponsor
- Vanda Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-25
- Primary completion
- 2021-11-19
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.